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In some cell systems, the antiproliferative effects of
8-Cl-cAMP, a site-selective cAMP analog speci®c for
the type I cAMP-dependent protein kinase, are medi-
ated by its metabolite, 8-Cl-adenosine. These effects
were once thought to be speci®c to transformed cells.
We investigated the ability of 8-Cl-adenosine to regu-
late growth and differentiation in primary cultures of
mouse epidermal keratinocytes. A 24 h exposure of
keratinocytes to 8-Cl-adenosine inhibited [3H]thymi-
dine incorporation in a dose-dependent manner with
an apparent IC50 of 7.5 mM, and these effects were
completely reversible. To determine the ability of
8-Cl-adenosine to induce differentiation of primary
keratinocytes, we measured keratin-1 expression and
transglutaminase activity, markers of early and later
stages of keratinocyte differentiation, respectively.
Interestingly, exposure of keratinocytes to 25 mM
8-Cl-adenosine for 24 h had no effect on keratin-1
expression or transglutaminase activity. The 8-Cl-
adenosine-induced growth arrest of keratinocytes
required uptake of the compound and was accom-
panied by an increase in protein expression of
the cyclin-dependent protein kinase inhibitor
p21WAF1/Cip1. These results demonstrate that 8-Cl-
adenosine inhibits growth in a nontransformed/non-
immortalized cell system, possibly through an eleva-
tion in p21WAF1/Cip1 protein levels, without inducing
differentiation. Key words: cell cycle/keratin-1/
p21WAF1/Cip1/transglutaminase. J Invest Dermatol 117:
1588±1593, 2001
R
ecently, much attention has been focused on the
use of nontoxic biologic agents that may poten-
tially restore regulatory control to cellular pro-
liferation in neoplastic cells. One such biologic
agent, 8-Cl-cAMP, has gained considerable atten-
tion due to its potent antiproliferative properties against trans-
formed cells. An initial phase I clinical trial using 8-Cl-cAMP as an
antineoplastic drug has been performed (Tortora et al, 1995).
Important, though, are the observations that in some cells the
antiproliferative effects of 8-Cl-cAMP are mediated by its
metabolite, 8-Cl-adenosine. For example, the 8-Cl-cAMP-in-
duced inhibition of proliferation and downregulation in mdr1
expression in the breast cancer cell line MCF7 is blocked if
adenosine deaminase activity, which converts adenosine to inosine,
is elevated in the culture medium (Scala et al, 1995). Also, 8-Cl-
cAMP-mediated inhibition of proliferation in CHO cells is almost
completely blocked when the cells are cultured in either serum-free
conditions or medium containing heat-inactivated serum (Van
Lookeren Campagne et al, 1991), conditions that reduce or
eliminate phosphodiesterase activity and inhibit the conversion of
8-Cl-cAMP to 8-Cl-adenosine. Along these same lines, use of a
phosphodiesterase-resistant form of 8-Cl-cAMP, Sp-8-Cl-cAMP,
but not the parental compound, failed to inhibit proliferation in the
colorectal cancer cell line LS174T (Carlson et al, 2001). And ®nally,
8-Cl-cAMP-induced inhibition of proliferation of nontransformed
®broblast, myoblast, and endothelial cells is dependent upon its
conversion to 8-Cl-adenosine (Han et al, 1993). Thus, in some cell
systems, the antiproliferative effects of 8-Cl-cAMP apparently are
mediated by 8-Cl-adenosine. In addition, it was once thought that
the antiproliferative effects of this nucleoside were speci®c to
transformed cells; however, 8-Cl-adenosine inhibits proliferation in
normal ®broblast, myoblast, and endothelial cells (Han et al, 1993),
as well as in both nontransformed and c-ras-transformed 3T3 cells
(Noguchi et al, 1998).
Primary epidermal keratinocytes represent a nontransformed cell
type that proliferates as part of its normal function. Speci®cally,
these cells continuously divide in vivo to regenerate epidermal cells
lost to the environment. Keratinocytes also differentiate in culture
in response to several agents (e.g., gangliosides GT1b and GQ1b,
elevated medium Ca2+ levels, and 1,25-dihydroxyvitamin D3).
These agents can induce markers of both early (e.g., keratin-1 and
keratin-10 expression) and late (e.g., transglutaminase activity)
differentiation (Yada et al, 1991; Paller et al, 1995; and reviewed in
Bikle and Pillai, 1993). In general, agents that induce keratinocyte
growth arrest also trigger the complete program of differentiation;
however, these two processes can be dissociated in the case of some
keratinocyte regulators. For example, transforming growth factor b
(TGF-b) induces growth arrest without an accompanying increase
in the expression of keratinocyte differentiation markers (Bikle and
Pillai, 1993; Hu et al, 1998); however, the mechanism of this
dissociation is unknown.
As discussed above, in many cell types the antiproliferative effects
of 8-Cl-cAMP are mediated by its metabolite, 8-Cl-adenosine. In
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addition, adenosine and its related adenine nucleotides (ATP, ADP,
AMP) inhibit proliferation in normal human keratinocytes (Cook
et al, 1995; Brown et al, 2000). The mechanism by which this
occurs is unknown at this time, however. In light of these studies,
we sought to determine if 8-Cl-adenosine exerted any antipro-
liferative effects against a nontransformed, nonimmortalized cell
system, primary mouse keratinocytes. We found that 8-Cl-
adenosine triggered reversible growth arrest of primary mouse
epidermal keratinocytes without inducing an increase in markers of
early or late differentiation. Thus, this compound appears to act in a
similar manner to TGF-b but is a small nonpeptide molecule
capable of inhibiting the proliferation of keratinocytes without
affecting their differentiation status.
MATERIALS AND METHODS
Materials 8-Cl-adenosine was purchased from Biolog (La Jolla, CA).
Anti-p21WAF1 (Ab-4), Oncogene Sciences (Cambridge, MA), and anti-
p21WAF1/Cip1 (13436E), Pharmingen (San Diego, CA), were used for
this study. Antikeratin-1 was purchased from Covance Research,
formerly Berkeley Antibody (Richmond, CA). Goat antimouse
horseradish peroxidase conjugate was purchased from Promega (Madison,
WI). SuperSignal Chemiluminescent substrate detection kits were
obtained from Pierce (Rockford, IL). Nitrocellulose was purchased from
Fisher Scienti®c. [3H]Thymidine, [3H]putrescine and [125I]-labeled goat
antirabbit IgG were purchased from Dupont/NEN (Boston, MA).
Propidium iodide was purchased from Molecular Probes (Eugene, OR).
All other reagents were obtained from standard suppliers and were of the
highest grade available.
Cell culture Primary epidermal keratinocytes were prepared from 1-
to 3-d-old neonatal ICR mice according to the method of Marcelo et al
(1978). Brie¯y, after trypsinization of the skin, the epidermis was
mechanically separated from the dermis and epidermal cells were released
by scraping. These cells were then collected by centrifugation and plated
in six-well dishes in keratinocyte medium consisting of minimum
essential medium containing 25 mM Ca2+, 2% (vol/vol) dialyzed fetal
bovine serum (FBS), 2 mM glutamine, 5 ng per ml epidermal growth
factor, ITS+ [6.25 mg per ml insulin, 6.25 mg per ml transferrin, 6.25 ng
per ml selenious acid + 5.35 mg per ml linoleic acid + 0.125% (wt/vol)
bovine serum albumin], 100 U per ml penicillin, 100 mg per ml
streptomycin, and 0.25 mg per ml fungizone. After an overnight
incubation, the cells were refed with serum-free keratinocyte medium
(SFKM), in which 2% (vol/vol) dialyzed FBS was replaced with 90 mg
per ml bovine pituitary extract. Cells were refed with fresh medium
every 1±3 d.
Measurement of DNA synthesis For measurement of [3H]thymidine
incorporation, near-con¯uent cultures were refed with SFKM containing
various concentrations of 8-Cl-adenosine. After the times indicated in
the ®gure legends, cells were labeled with 1 mCi per ml [3H]thymidine
for an additional hour in the continued presence of 8-Cl-adenosine.
Cultures were washed twice with phosphate-buffered saline without
calcium or magnesium (PBS±) and reactions were terminated using ice-
cold 5% trichloroacetic acid (TCA). Cells were washed with an
additional volume of 5% TCA and with distilled water, and were
solubilized in 0.3 M NaOH for 10 min at 50°C. The amount of
[3H]thymidine incorporated into DNA was determined by liquid
scintillation counting.
Flow cytometric analysis Unsynchronized near-con¯uent cultures of
keratinocytes were refed with SFKM containing the indicated agents.
After 24 h, the media as well as one 1 3 PBS± wash (to obtain ¯oating
cells) were collected. The attached cells were harvested and pooled with
the cells that had become detached. In some experiments the media and
the PBS± wash were aspirated and only the attached cells were collected
and processed for ¯ow cytometric analysis. The combined cell pellet was
washed once with ice-cold PBS±, gently resuspended in ice-cold 70%
EtOH, and stored at 4°C until processing. DNA content of the nuclei
was determined by staining nuclear DNA with propidium iodide (50 mg
per ml, 30 min) and measuring the relative DNA content of nuclei of
10,000 events, using a Becton Dickinson FACSCalibur ¯uorescence-
activated cell sorter. MODFIT DNA and CELLQUEST analysis
software were utilized to determine the proportion of nuclei in each
phase of the cell cycle.
Western blot analysis Cellular proteins were quanti®ed using the Bio-
Rad DC protein assay system (Bio-Rad, Hercules, CA), with bovine
serum albumin as standard. Equal amounts of proteins (25±50 mg) were
then resolved through 10% sodium dodecyl sulfate polyacrylamide gels
and transferred to nitrocellulose using either a semidry or wet transfer
apparatus. In the case of the p21WAF1/Cip1 Westerns, electroblots were
probed with anti-p21WAF1 (Ab-4) [diluted 1:100 in 1 3 PBS
containing 2% (wt/vol) nonfat milk and 0.1% (vol/vol) Tween-20] for
16 h at 4°C. The blots were washed three times (10 min each) with 1 3
PBS/0.1% Tween-20 and exposed to goat antimouse horseradish
peroxidase (diluted 1:5000 in 1 3 PBS containing 2% nonfat milk and
0.1% Tween-20) for 2 h at room temperature. The blots were washed
again as described above. In this study, we also used an antimouse
p21WAF1/Cip1 antibody (13436E), according to the manufacturer's
guidelines. Western blot analysis for keratin-1 (diluted 1:500) was
performed using a previously described protocol (Towbin, 1979). For
the p21WAF1/Cip1 Westerns, immunoreactive proteins were visualized
using standard enhanced chemiluminescent techniques (SuperSignal,
Pierce). Immunoreactive keratin-1 protein was visualized using 125I-
labeled goat antirabbit IgG and quanti®ed by PhosphorImager analysis
(Molecular Dynamics, Sunnyvale, CA).
Measurement of transglutaminase activity Near-con¯uent keratino-
cytes were incubated for 24 h with the indicated agents in SFKM. The
cells were washed with PBS±, scraped into homogenization buffer
[0.1 M Tris-acetate, pH 7.8, 2 mg per ml aprotinin, 2 mM leupeptin,
1 mM pepstatin A, 0.2 mM ethylenediamine tetraacetic acid (EDTA),
0.2 mM phenylmethylsulfonyl ¯uoride, and 0.1% (vol/vol) b-mercapto-
ethanol], placed into microcentrifuge tubes, and pelleted by
centrifugation. The supernatants were removed and the cell pellets were
subjected to one freeze±thaw cycle prior to disruption by sonication in
homogenization buffer. Aliquots of the homogenate were incubated
overnight (16±18 h) at 37°C with 2 mCi per sample [3H]putrescine in a
reaction mixture containing 1% (wt/vol) dimethylated Hammerstein
casein, 0.1 M Tris-acetate (pH 8.5), 10 mM CaCl2, 0.1 mM EDTA,
25 mM dithiothreitol, and 0.1% (vol/vol) Triton X-100 (®nal
concentrations). Reactions were terminated by adding TCA (to a ®nal
concentration of 5%) and the samples were ®ltered through glass-®ber
®lters. After thorough washing with 5% TCA, the ®lters were counted
by liquid scintillation spectrometry. Cellular protein content of the
samples was determined as described above.
Statistical analysis The signi®cance of differences between mean
values was determined using ANOVA, as performed by the program
Instat (GraphPad Software, San Diego, CA).
RESULTS
8-Cl-adenosine inhibits proliferation in primary mouse
keratinocytes in a dose- and time-dependent manner In
this study we sought to determine whether 8-Cl-adenosine, an
agent known to induce growth arrest and/or differentiation in
transformed cells (Carlson et al, 2000; 2001) and nontransformed
cells (Han et al, 1993), could elicit growth arrest and/or
differentiation in a nontransformed/nonimmortalized primary
cell, whose principal function depends in part upon continuous
proliferation. A 24 h exposure of keratinocytes to 8-Cl-adenosine
inhibited [3H]thymidine incorporation in a dose-dependent
manner with an apparent IC50 of 7.5 mM (Fig 1A). 8-Cl-
adenosine inhibited growth of primary mouse keratinocytes
within 1 h of treatment with a 70%±80% inhibition of
[3H]thymidine incorporation observed after 24 h (Fig 1B).
Maximal inhibition was observed between 18 and 24 h (Fig 1B).
The growth inhibitory effects of 8-Cl-adenosine are
completely reversible Previous studies have demonstrated
that 8-Cl-adenosine exerts an irreversible inhibition of
proliferation in colorectal cancer cells (Tagliaferri et al, 1988). We
sought to determine if the antiproliferative effects we observed in
primary mouse keratinocytes exhibited a similar phenomenon.
Treatment of keratinocytes with 8-Cl-adenosine for either 24 or
48 h followed by agonist removal and replenishment of fresh
medium resulted in a reversible growth inhibition of these cells
(Fig 2). Not only did these cells reestablish their proliferative
capabilities but the cells that had been treated with 8-Cl-adenosine
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for 24 h exhibited growth rates greater than those cells that had not
been previously exposed to 8-Cl-adenosine.
8-Cl-adenosine induces a G0/G1 cell cycle arrest We
utilized ¯ow cytometric analysis to address changes in cell cycle
pro®le relative to cellular growth/proliferation in primary mouse
keratinocytes. In pooled attached and detached cells, 8-Cl-
adenosine induced a signi®cant increase in the population of
keratinocytes in G0/G1 concomitant with a decrease in the number
of cells in S phase (Table I). These results were similar to those
observed in keratinocytes treated with TGF-b, a known inducer of
G0/G1 arrest in a number of cell systems (Hu et al, 1998), including
keratinocytes (Alexandrow and Moses, 1995). A small but
statistically signi®cant increase in the proportion of cells in G2/M
was also detected in 8-Cl-adenosine-treated keratinocytes. On the
other hand, there was no increase in the number of cells in the sub-
G0/G1 phase, generally considered to be indicative of apoptotic
cells. In additional experiments, we examined the effect of 8-Cl-
adenosine on attached cells only. Again, 8-Cl-adenosine decreased
the proportion of cells in S phase and increased the percentage of
cells in G0/G1 (Table II). These results were similar to the effects
observed when the attached and detached cells were pooled and
analyzed (Table I) and were also once more similar to the effects of
TGF-b.
8-Cl-adenosine does not cause keratinocyte differenti-
ation Numerous agents that elicit growth arrest of keratino-
cytes also trigger their differentiation. Therefore, we sought to
determine if 8-Cl-adenosine induced a differentiated phenotype in
keratinocytes. We analyzed 8-Cl-adenosine-treated keratinocytes
for either keratin-1 expression or transglutaminase activity, early
and later differentiation markers, respectively. Keratinocytes were
treated for 18 or 24 h with 8-Cl-adenosine and analyzed for
keratin-1 expression by Western blot analysis. Figure 3(A)
illustrates representative Western blots demonstrating that 8-Cl-
adenosine did not increase expression of this differentiation marker.
On the other hand, the positive controls, elevated extracellular
Ca2+ levels (125 mM) and 1,25-dihydroxyvitamin D3 (10 nM),
both inducers of differentiation in keratinocytes (reviewed in Bikle
and Pillai, 1993), increased keratin-1 protein expression (Fig 3A).
PhosphorImager densitometric analysis revealed that Ca2+ and
1,25-dihydroxyvitamin D3 increased keratin-1 protein expression
from 2- to 8-fold over control-treated keratinocytes (Fig 3B). 8-
Cl-adenosine had no effect on keratin-1 protein expression. In
addition, a 24 h exposure to 8-Cl-adenosine failed to alter
transglutaminase activity, a marker of late-stage differentiation, at
concentrations of either 10 or 25 mM. On the other hand, the
positive control, elevated extracellular Ca2+ levels (1 mM),
increased transglutaminase activity 8-fold over that observed in
control-treated keratinocytes (Fig 4). A longer (48 h) exposure to
Figure 2. The 8-Cl-adenosine-induced inhibition of proliferation
is completely reversible. Primary mouse keratinocytes were treated
with 8-Cl-adenosine (8-Cl-ad) (10 or 25 mM) or control vehicle (H2O)
for 24 (hatched bars) or 48 (open bars) h. The cells were washed twice
with PBS± and once with SFKM prior to the addition of fresh SFKM
6 8-Cl-ad (10 or 25 mM). The cells were incubated for an additional
24 h prior to measuring the incorporation of [3H]thymidine (Materials
and Methods). Data represent the mean 6 SEM of four experiments; *p
< 0.01 compared to control-treated cells.
Figure 1. 8-Cl-adenosine inhibits growth in a dose- and time-
dependent manner. Primary mouse keratinocytes were treated with
the indicated concentrations of 8-Cl-adenosine for 24 h (a) or with
10 mM (j) or 25 mM (s) 8-Cl-adenosine for the indicated times (b),
and [3H]thymidine incorporation was determined as indicated in Materials
and Methods. Data represent the mean 6 SEM of seven (a) and four (b)
experiments. (a) *p < 0.01; (b) all values signi®cantly different from
control-treated cells, p < 0.01.
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8-Cl-adenosine also failed to increase transglutaminase activity
(0.65-fold 6 0.08-fold over control), although again the positive
control of elevated extracellular Ca2+ levels (1 mM) stimulated
activity (6.5-fold 6 1.5-fold over control, n = 3; p < 0.001).
Potential mechanisms of 8-Cl-adenosine-induced growth
arrest Recent data from the laboratory of Dr. Paul Cook has
indicated that adenosine analogs can inhibit keratinocyte growth by
a mechanism that requires uptake of the compounds into the cell
(Brown et al, 2000). To determine if a similar requirement for
uptake of 8-Cl-adenosine exists, we examined the effect of the
nucleoside transport inhibitor nitrobenzylthioinosine (NBTI) on
8-Cl-adenosine-induced growth arrest by ¯ow cytometric analysis.
We have previously shown that 100 mM NBTI inhibits more than
90% of the uptake of the nucleoside thymidine into keratinocytes
(Griner and Bollag, 2000). Preventing uptake of 8-Cl-adenosine
into keratinocytes with NBTI blocked the ability of 8-Cl-
adenosine to reduce the proportion of cells in the S phase and
increase the percentage in G0/G1 (Table III). Thus, our results
indicate that uptake of 8-Cl-adenosine into the cells is necessary for
the compound to elicit growth arrest.
Regulation of G0/G1 cell cycle arrest has been attributed to a
number of cellular proteins, including p53, the CDK inhibitors
(p21WAF1/Cip1, p27Kip1, and p57Kip2), and the speci®c inhibitors of
CDK4 and CDK6 (p16INK4a, p15INK4b, p18INK4c, and p19INK4d),
known as the INK4 proteins (Sherr, 1996). We investigated the
effect of 8-Cl-adenosine on p21WAF1/Cip1, because of its recog-
nized importance to keratinocyte growth arrest (Missero et al, 1995,
1996; Di Cunto et al, 1998). Western blot analysis of 8-Cl-
adenosine-treated primary mouse keratinocytes revealed an increase
in the levels of p21WAF1/Cip1 protein above control-treated cultures
at as early as 6 h of treatment (data not shown) with a pronounced
2- to 3-fold increase observed by 16±24 h of exposure (Fig 5).
DISCUSSION
It has become increasingly clear that the use of 8-Cl-cAMP or
8-Cl-adenosine for the control of cellular proliferation is not as
simple as once believed. It now appears that this cAMP analog and
its active metabolite exert differential effects on a wide variety of
cells. In some cases, the antiproliferative effects of 8-Cl-cAMP are
mediated by 8-Cl-adenosine (Van Lookeren Campagne et al, 1991;
Scala et al, 1995), whereas in some cell systems 8-Cl-cAMP inhibits
growth independent of its conversion to 8-Cl-adenosine (Noguchi
et al, 1998). In any event, the signal transduction mechanisms by
which either of these two agents induce their antiproliferative
effects has not been clearly de®ned. We have sought to determine
the effect of 8-Cl-adenosine on the growth of a nontransformed/
nonimmortalized cell system, primary cultures of mouse keratino-
cytes. We chose this cell system because in vivo keratinocytes must
proliferate as part of their normal function; thus these cells represent
a good model for investigating antiproliferative effects in a normal
cell type.
8-Cl-adenosine inhibited growth in primary cultures of mouse
keratinocytes in a dose- and time-dependent manner (Fig 1).
Interestingly, the effects of 8-Cl-adenosine on keratinocyte growth
were completely reversible (Fig 2). These ®ndings are in contrast
to the irreversible growth inhibitory effects observed in the
Table I. 8-Cl-adenosine induces growth arrest
G0/G1 S G2/M
Control 75.4 6 1.0ab 12.6 6 1.5 12.0 6 1.0
8-Cl-adenosinec 79.1 6 1.1* 6.4 6 0.9*** 14.6 6 1.5*
TGF-b 80.9 6 0.8* 8.0 6 1.0** 11.1 6 1.1
aSamples represent the means 6 SEM of six separate experiments performed in
duplicate; *p < 0.05; **p < 0.01 and ***p < 0.001 versus the control value by
repeated measures ANOVA analysis.
bThe sub-G0/G1 population for the three treatments was not statistically
different.
cConcentrations of 25 mM 8-Cl-adenosine and 5 ng per ml TGFb were used.
Table II. 8-Cl-adenosine induces growth arrest in attached
cells
G0/G1 S G2/M
Control 55.1 6 0.3ab 28.0 6 0.6 16.9 6 0.4
8-Cl-adenosinec 64.2 6 0.8*** 18.8 6 1.0*** 17.1 6 0.3
TGF-b 65.5 6 1.5*** 17.3 6 0.2*** 17.3 6 1.4
aSamples represent the means 6 SEM of six separate experiments performed in
duplicate; *p < 0.05 and ***p < 0.001 versus the control value by repeated
measures ANOVA analysis.
bThe sub-G0/G1 population for the three treatments was less than 1% of the po-
pulation of cells.
cConcentrations of 25 mM 8-Cl-adenosine and 5 ng per ml TGFb were used.
Figure 3. 8-Cl-adenosine does not increase keratin-1 expression.
Primary mouse keratinocytes were treated with 8-Cl-adenosine (8-Cl-ad,
25 mM) or control vehicle (H2O) in 25 mM Ca2+-SFKM for 18 or 24 h
and keratin-1 protein expression was determined by Western blot
analysis as described in Materials and Methods. Elevated medium calcium
concentration (Ca2+, 125 mM Ca2+-SFKM) and 1,25 dihydroxyvitamin
D3 (D3, 10 nM) were used as positive controls. (A) Representative blots
of three experiments yielding similar results; (B) Phosphorimager
quantitation of K1 expression expressed as fold over the control value of
1.0. Data represent the mean 6 SEM of three experiments; *p < 0.01
compared to control-treated cells.
VOL. 117, NO. 6 DECEMBER 2001 8-Cl-ADENOSINE INHIBITS GROWTH OF KERATINOCYTES 1591
colorectal cancer cell line LS174T (Tagliaferri et al, 1988) and
suggest the potential for differences in the mechanism by which this
nucleoside inhibits growth in nontransformed versus transformed
cells. Along these lines, 8-Cl-adenosine induces apoptosis in several
colorectal cancer cell lines (Carlson et al, 2000), whereas we did not
detect any apoptosis in 8-Cl-adenosine-treated keratinocytes
(Table I). Interestingly, treatment with 8-Cl-adenosine for 24 h
and its subsequent removal resulted in enhanced [3H]thymidine
incorporation relative to control cultures. This ``rebound'' effect is
probably due to the fact that keratinocyte proliferation decreases
signi®cantly (but does not cease) once the cells attain con¯uence.
Thus, if the cells are prevented from becoming completely
con¯uent by 8-Cl-adenosine treatment, removal of the 8-Cl-
adenosine-induced inhibition will lead to enhancement of DNA
synthesis relative to the con¯uence-inhibited control cultures.
Flow cytometric analysis revealed that 8-Cl-adenosine induced a
G0/G1 arrest. This cell cycle arrest was associated with elevations in
the cyclin-dependent kinase inhibitor p21WAF1/CIP1 (Fig 5). We
do not know at this time if removal of 8-Cl-adenosine, a condition
that releases keratinocytes from their apparent cell cycle arrest,
results in a decline in the protein levels of p21WAF1/Cip1. Elevation
in p21WAF1/Cip1 protein is associated with differentiation in a
number of cell systems (Jiang et al, 1994; Datto et al, 1995; Missero
et al, 1995). 8-Cl-adenosine-induced elevations in p21WAF1/Cip1
protein, however, were not accompanied by keratinocyte differ-
entiation, as determined by changes in keratin-1 expression or
transglutaminase activity between 18 and 48 h of treatment
(Figs 3, 4). These results are similar to that observed with
TGF-b (an inducer of p21WAF1/Cip1) in that G0/G1 arrest occurs
without a concomitant induction of differentiation (Hu et al, 1998).
Dotto and colleagues, however, reported that p21WAF1/Cip1-
knockout mouse keratinocytes exhibited a downregulation in the
late-stage keratinocyte differentiation markers loricrin and involu-
crin (Missero et al, 1996), suggesting that p21WAF1/Cip1 is required
for this stage of differentiation in keratinocytes. This effect was not
observed in keratinocytes devoid of the closely related cyclin-
dependent kinase inhibitor p27Kip1 (Missero et al, 1996). On the
other hand, overexpression of p21WAF1/Cip1 was also found to
prevent differentiation marker expression (Di Cunto et al, 1998).
Thus, the exact role of p21WAF1/Cip1 in the control of keratinocyte
differentiation has yet to be clari®ed.
The mechanism through which 8-Cl-adenosine increases
p21WAF1/Cip1 expression and exerts its growth inhibitory effect is
not clear. In studies in progress we have observed an 8-Cl-
adenosine-elicited increase in keratinocyte p53 protein levels by
approximately 4 h (data not shown). Similarly, in colorectal cancer
cells both p53 and p21WAF1/CIP1 levels increase upon treatment
with 8-Cl-adenosine (Carlson et al, 2001). p21WAF1/CIP1 levels also
are elevated in p53 mutant cells, however, (Drans®eld et al,
unpublished observations), suggesting perhaps both p53-dependent
and -independent mechanisms for the 8-Cl-adenosine-induced rise
in p21WAF1/CIP1 levels. In addition, results with the nucleoside
transport inhibitor NBTI suggest that uptake of the compound into
the cells is required. This ®nding is similar to the data of Brown et al
(2000), in which inhibition of entry of physiologic adenosine
analogs (adenosine, AMP, ADP, and ATP) into human keratino-
cytes prevented the antiproliferative activity of these agents.
Another similarity between our results and the data obtained
Figure 4. 8-Cl-adenosine does not elevate transglutaminase
activity. Primary mouse keratinocytes were treated with 8-Cl-adenosine
(8-Cl-ad, 25 mM) or control vehicle (H2O) in 25 mM Ca2+-SFKM for
24 h and transglutaminase activity was determined as described in
Materials and Methods. Elevated medium Ca2+ concentration (1 mM
Ca2+-SFKM) was used as a positive control. Data represent the mean
6 SEM of four experiments; *p < 0.01 compared to control-treated cells.
Table III. The nucleotide transport inhibitor NBTI
prevents 8-Cl-adenosine-induced growth arrest
G0/G1 S G2/M
Control 74.6 6 2.7ab 15.0 6 2.0 10.4 6 0.7
NBTIc 70.6 6 3.1*** 16.4 6 2.1 13.0 6 1.2**
8-Cl-adenosine 78.9 6 2.4*** 8.7 6 1.4*** 12.2 6 1.3*
8-Cl-adenosine + NBTI 73.0 6 3.1² 15.1 6 2.1² 12.0 6 1.1*
aSamples represent the means SEM of six separate experiments performed in
duplicate; *p < 0.05, **p < 0.01, and ***p < 0.001 versus the control value;
²p < 0.001 versus 8-Cl-adenosine alone by repeated measures ANOVA analysis.
bThe sub-G0/G1 population for the four treatments was not statistically different.
cConcentrations of 25 mM 8-Cl-adenosine and 100 mM NBTI were used.
Figure 5. 8-Cl-adenosine upregulates p21WAF1/CIP1 protein levels.
Primary mouse keratinocytes were treated with 8-Cl-adenosine (Ad,
25 mM) or control vehicle (C, H2O) for the indicated times and
p21WAF1/CIP1 protein expression was determined by Western blot and
subsequent densitometric analysis as described in Materials and Methods
(stippled bar, 16 h; gray bar, 24 h). Data represent the mean 6 SEM of
®ve to eight experiments expressed as fold over the control value of 1.0;
#p < 0.05 compared to control-treated cells by a nonparametric Kruskal±
Wallis ANOVA test. Inset: representative Western blot.
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with adenosine analogs is the reversibility of the effects (Fig 2 and
Cook et al, 1995). Nevertheless, there are distinct differences as
well. For instance, Brown et al (2000) found that adenosine analogs
arrested cells in S phase, whereas we observe 8-Cl-adenosine-
induced arrest primarily in G0/G1 (Tables I, II). These disparities
may or may not be due to differences in methodology (24 h vs 48 h
incubations with agents and/or varying degrees of subcon¯uence)
or species (mouse versus human). Cook and colleagues (Cook et al,
1995; Brown et al, 2000) also did not determine the effects of the
adenosine analogs on markers of keratinocyte differentiation. Thus,
it is not clear whether 8-Cl-adenosine inhibits growth via a novel
mechanism or through one similar to that utilized by physiologic
adenosine analogs.
Phase II trials of 8-Cl-cAMP for treatment of human cancers are
in progress (McDaid and Johnston, 1999). The mechanism of 8-Cl-
cAMP inhibition of cancer cell proliferation is unknown but is
likely to involve conversion of 8-Cl-cAMP to 8-Cl-adenosine
(Van Lookeren Campagne et al, 1991; Han et al, 1993; Scala et al,
1995; Halgren et al, 2001; Yin et al, 2001). Similarly, 8-Cl-cAMP
induces apoptotic cell death in some cancer cell lines through its
8-Cl-adenosine metabolite (Halgren et al, 2001; Yin et al, 2001).
On the other hand, we have found that 8-Cl-cAMP is less potent
than 8-Cl-adenosine at inhibiting normal keratinocyte proliferation
(data not shown). In addition, our results suggest that 8-Cl-
adenosine does not induce apoptosis in normal keratinocytes but
instead causes a reversible G0/G1 growth arrest. Therefore, whereas
8-Cl-adenosine may temporarily inhibit keratinocyte proliferation,
the reversibility of this effect should preclude any long-term
negative consequences. Indeed, in athymic mice in vivo adminis-
tration of 8-Cl-adenosine inhibits tumor formation by a colorectal
cancer cell line without signi®cant toxicity (Carlson et al, 2000).
Thus, by sparing the stem cells and/or transit-amplifying cells of the
epidermis while triggering apoptosis in cancer cells, both 8-Cl-
cAMP and its metabolite 8-Cl-adenosine should exhibit little skin
toxicity and hopefully prove to be a useful therapy for treatment of
human cancers.
Taken together, these data suggest (i) that 8-Cl-adenosine can
inhibit growth of a nontransformed/nonimmortalized cell, primary
mouse keratinocytes, and (ii) this growth inhibition is dissociated
from the induction of the keratinocyte differentiation program.
Thus, 8-Cl-adenosine represents a small nonpeptide molecule that,
like TGF-b, is capable of arresting keratinocyte growth without
eliciting differentiation. Finally, it should be noted that careful
consideration must be applied when investigating the apparent cell
speci®city and mechanisms by which the antiproliferative effects of
8-Cl-adenosine are exerted.
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